Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells.
Saved in:
| Title: | Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells. |
|---|---|
| Authors: | Stanglmaier, Michael m.stanglmaier@gmx.de, Reis, Simone simone.reis@medizin.uni-ulm.de, Hallek, Michael michael.hallek@med3.med.uni-muenchen.de |
| Source: | Annals of Hematology. Oct2004, Vol. 83 Issue 10, p634-645. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09395555 |
|---|---|
| DOI: | 10.1007/s00277-004-0917-0 |
